Recommended Pages at www1.actelion.com
index
www1.actelion.com — “Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs. Find here the latest news & events.” View full resource at www1.actelion.com
Most Recently Shared on August 13, 2009 at 7:07 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
Bosentan (Tracleer®) now approved by FDA in addition to Ambrisentan (Letairis®) for WHO class II PAH patients. : http://tinyurl.com/mvta7q
index -
www1.actelion.com — “Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs. Find here the latest news & events.” View full resource at www1.actelion.com
Most Recently Shared on August 13, 2009 at 7:04 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
Higher dose inhaled ventavis FDA approved to decrease inhalation times and improve compliance in pts with PAH : http://tinyurl.com/mvs2gq
index -
www1.actelion.com — “Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs. Find here the latest news & events.” View full resource at www1.actelion.com
Most Recently Shared on July 20, 2009 at 4:05 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
New oral prostacyclin showed favorable effects in Phase IIa trial, now to enter Phase III trials. http://tinyurl.com/npgl3y
